BioHealth News Archive
Global pandemic center will be in Rockville medical office building
A global center focusing on pandemic prevention and biodefense work will be in Rockville, county officials and partners in the project said Wednesday. Connected…
Read MoreHarnessing the power of monoclonal antibodies in virology
Monoclonal antibodies have become one of humanity’s most powerful, multi-use tools in biology and medicine. Once the field of immunology established that they could…
Read MoreEvusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the pre-exposure prophylaxis…
Read MoreSupernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company focused on developing and commercializing products for the…
Read MoreMontgomery County, MD Chosen for Global Pandemic Prevention and Biodefense Center Headquarters — MCEDC
Rockville, Md. — Montgomery County is home to the new Global Pandemic Prevention and Biodefense Center launched by Connected DMV. The Center will be co-located…
Read MoreTime of day matters when getting COVID vaccine – Harvard Gazette
Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination. A new study published in the Journal…
Read MoreIonQ Leads Charge for Quantum Commercialization at Q2B 2021
COLLEGE PARK, Md., December 07, 2021--(BUSINESS WIRE)--IonQ, Inc. ("IonQ") (NYSE: IONQ), a leader in trapped-ion quantum computing, today announced its participation at the fifth…
Read MoreWhere New Medical Devices Come From | by John G Younger | Bioeconomy.XYZ | Nov, 2021 | Medium
The transition from Angel to institutional funding is a key step (but not quite an absolute requirement) in the evolution of a start-up bringing…
Read MoreSeed Funds | TEDCO
We work alongside our entrepreneurs as partners to drive the next wave of startups. We leverage our diverse operating and investing experience to uncover…
Read MoreInnoforce Pharmaceuticals
Innoforce (“INF”), a biopharmaceutical manufacturing & development company, announced today the completion of a 1 billion CNY ($156.6M) Series A financing, with the closing of an…
Read MoreBaltimore should be investing more in ‘wet labs’ | READER COMMENTARY
The critical shortage of “wet lab” space in Baltimore is an indictment of a city economic development strategy more concerned with real estate development…
Read MoreBD finalizes name and leadership for its billion-dollar diabetes spinoff | FierceBiotech
BD has settled on a new name for its new company, the independent spinout that will house its billion-dollar diabetes care business. Embecta is…
Read MoreAccellix Raises $10 Million From BroadOak Capital Partners
SAN JOSE, Calif. & BETHESDA, Md.--(BUSINESS WIRE)--Accellix Inc., which provides quick and accurate flow cytometry results in a compact and easy-to-use platform designed for…
Read MoreThe Maryland Stem Cell Research Fund (MSCRF) Grant Programs Now Accepting Applications
The Maryland Stem Cell Research Fund (MSCRF) offers six grant programs to accelerate human stem cell-based research, commercialization, and cures. The six programs are designed to support scientists…
Read MoreNexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
Initial Phase 1/2 data presented at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition Phase 1/2 study of NEXI-002 as a…
Read More